Global Heart Pump Devices Market Future Growth, Business Trends and Key Players like Boston Scientific, Boston Scientific Cardiology, CryoLife Inc., Medtronic, Abbott, Reliantheart, Terumo Europe NV, Berlin Heart, Jarvik Heart,Cardiacassist, Getinge AB
Try a free sample of this report now https://databridgemarketresearch.com/request-a-sample/?dbmr=global-heart-pump-device-market
Well known players of Heart Pump Device Market are Abbott, Abiomed, Medtronic, Getinge, Maquet Getinge Group, Syncardia Systems, Teleflex, HeartWare International Inc., Berlin Heart GmbH, Getinge AB, Fresenius Medical Care, Syncardia Systems, Reliantheart, Terumo Europe NV, Berlin Heart, Jarvik Heart, Cardiacassist, Thoratec Corporation, Jarvik Heart, Inc. among others.
Based on geography, the market report covers data points for 28 countries across multiple geographies namely
• North America & South America,
• Asia-Pacific and,
• Middle East & Africa
Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa and, Brazil among others.
On the basis of therapy, the market is segmented into
• bridge-to-transplant (BTT),
• bridge-to-candidacy (BTC),
• destination therapy (DT) and other therapies
Based on product, the market is segmented into
• ventricular assist devices (VADs),
• intra-aortic balloon pumps (IABPs) and t
• Total artificial heart (TAH)
The ventricular assist devices (VADs) segment is further sub-segmented into left ventricular assist devices (LVADs), right ventricular assist devices (RVADs), Bi-ventricular assist devices (BiVADs) and percutaneous ventricular assist devices (pVADs).
On the basis of type, the market is classified into
• implantable heart pump devices and
• extracorporeal heart pump devices
FREE Table of Contents (TOC) Available at https://databridgemarketresearch.com/toc/?dbmr=global-heart-pump-device-market
Abbott founded in 1888 and headquarters in Illinois, U.S., focuses on manufacturing products for diagnostics, medical devices, nutrition and branded generic pharmaceuticals. It operates its business through Established Pharmaceuticals, Nutritionals, Diagnostics, Cardiovascular and Neuromodulation and Others. It offers heart pumps products through its cardiovascular and neuromodulation.
The company has its presence in U.S., China, Germany, Japan, India, The Netherland, Switzerland, Russia, France, Brazil, Italy, U.K., Colombia, Canada, Vietnam and others. It has its subsidiaries worldwide such as Alere Inc. (U.S.), Abbott Medical Optics Inc. (U.S.), EAS (U.S.), Abbott India Ltd (India), Thoratec Corporation (U.S.) and others.
• In January 2017, Abbott (U.S.) acquired ST. JUDE MEDICAL (U.S.). This acquisition expanded Abbott (U.S.) opportunities for future growth and development of strong, diverse portfolio of devices, diagnostics, nutritionals and branded generic pharmaceuticals.
Getinge AB, founded in 1904 and based in Sweden. It is involved in designing, manufacturing and marketing of equipment and systems for healthcare and life sciences. It operates its business through acute care therapies and surgical workflows. It offers heart pump devices through its subsidiary Maquet (Germany). The company has its presence in North America, South America, Asia Pacific, Europe, Middle East and Africa.
• In Feburary 2014, Getinge AB (Sweden) acquired Pulsion Medical Systems (Germany). This acquisition has expanded business of the company.
For any queries, Speak to our Research Analyst at https://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-heart-pump-device-market
Major Drivers of Heart Pump Device Market
Prominent factors driving the growth of this market consist of increasing incidence of cardiac disease, rapid advancement in surgical technique in VAD implantation, increasing popularity of minimal invasive surgical procedures in cardiology, regulatory approval of heart pump devices are fuel the growth of heart pump devices market.
Increasing Incidence of Cardiac Diseases:
According to Health Data Government, world population from past increase 7 billion and increasing the number of geriatric population. So the number of death from cardiovascular diseases is also increasing. As per the European Society of Cardiology in 2014, approximately 26 million people in all over world suffering from heart failure. Cardiac diseases such as heart attacks, strokes and other circulatory disease is the major cause of premature death in the world.
Increasing regulatory approval and reimbursement procedure of heart pump devices:
Regulatory approval is defined as that approvals by government pricing or health authorities in a country (including FDA and EMEA), product and establishment licenses, registrations or authorizations of any federal, state or local regulatory agency, department, bureau or other governmental entity, in each case. These regulatory approvals are necessary for the commercial manufacture, usage, storage, importation, export, transport or sale of collaboration products in a regulatory jurisdiction. Different countries have different regulatory body for medical device licensing. In India, cardiac implantable medical devices are listed under the classification of medical device rules with regulatory approval and registration by the CDSCO (Central Drug Standard Controller Organization).The CDSCO (Central Drug Standard Controller Organization) is govern by the Drug Controller General of India (DCGI).
For Customized Reports and Discounts, Mail us at email@example.com
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge Market Research
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Heart Pump Devices Market Future Growth, Business Trends and Key Players like Boston Scientific, Boston Scientific Cardiology, CryoLife Inc., Medtronic, Abbott, Reliantheart, Terumo Europe NV, Berlin Heart, Jarvik Heart,Cardiacassist, Getinge AB here
News-ID: 1534307 • Views: 485
More Releases from Data Bridge Market Research
Small-Scale LNG Market Competitive Analysis and Economic Forecasting | Linde, Wa …
Small-Scale LNG Market analysis report is a skilful and deep analysis of the present situation and challenges. This market research report combines secondary research which includes reference to different statistical databases, related patent and regulatory bibliography and a number of internal and external proprietary information. With the help of key information and Small-Scale LNG Market insights from technical and marketing experts, the report offers an objective estimation of the Small-Scale
FTTx Market Massive Growth by 2026 with | Altibox, A1 Mtel , NBN Co ltd, NetColo …
FTTx Market report studies the size, industry status and forecast, competition landscape and growth opportunity. FTTx Market research report categorizes by the companies, region, type, end-user of industry and Many More. FTTx Market research report is generated with a nice blend of industry insight, talent solutions, practical solutions and use of technology to advance user experience. The key research methodology used in this FTTx Market report by DBMR research team is
Nanomagents Market Set up an Enormous Growth by | Novanta, Rofin-Sinar Technolog …
Nanomagents Market report studies the size, industry status and forecast, competition landscape and growth opportunity. Nanomagents Market research report categorizes by the companies, region, type, end-user of industry and Many More. Nanomagents Market research report is generated with a nice blend of industry insight, talent solutions, practical solutions and use of technology to advance user experience. The key research methodology used in this Nanomagents Market report by DBMR research team is
Enterprise File Synchronization and Sharing Market Competitive Outlook | Accelli …
Enterprise File Synchronization and Sharing Market report studies the size, industry status and forecast, competition landscape and growth opportunity. Enterprise File Synchronization and Sharing Market research report categorizes by the companies, region, type, end-user of industry and Many More. Enterprise File Synchronization and Sharing Market research report is generated with a nice blend of industry insight, talent solutions, practical solutions and use of technology to advance user experience. The key research
More Releases for Heart
Heart Congress 2019
Coalesce Research Group proudly announces the “International Conference on Heart & Clinical Cardiology Research” at Osaka, Japan during November 14-15, 2019. This Conference will be perfect platform for scientists, professors, healthcare professionals and cardiologists. Heart Congress 2019 is designed to provide diverse and recent research education on cardiovascular disease that keeps medical professionals along with issues heartrending on diagnosis, treatment of Cardiac disorders and prevention. In recent years, cardiac and
Heart Pump Device Market - Potential Innovations 2025 | Terumo, Jarvik Heart
Heart Pump Device Market: Snapshot Heart pump devices are essentially mechanical pumps playing the role of ventricular assist devices. These are surgically implanted and are used for temporarily supporting the functions of heart in people with weak heart or irregular blood flow. These devices are notably used as a bridge to cardiac transplantation for patients suffering with end stage heart failure. They can also be used in patients during and after
Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017, provides an overview of the Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline landscape. Heart failure is also known as congestive heart failure (CHF).
Congestive Heart Failure (Heart Failure) Market Research Report
Latest industry research report on: Congestive Heart Failure (Heart Failure) Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts GlobalData's clinical trial report, Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2017" provides an overview of Congestive Heart Failure (Heart Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Congestive Heart Failure (Heart Failure). Report includes an
Prosthetic Heart Valve Market
Prosthetic (artificial) heart valve refers to a device implanted in the heart of a patient suffering from valvular heart disease. A cardiac surgery is performed to replace the abnormal heart valve with a prosthetic heart valve. Replacement of a diseased valve with a prosthetic heart valve results in reduction in morbidity and mortality associated with the cardiac valve disorder. When the treatment of heart valve disease reaches a stage where
Global Heart Implants Market
The Heart Implants Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. In a growing cardiac implants market where profits and growth prospects run together, many companies are vying to plunge into this untapped market. Heart implants are end-stage operations, where a failing